Neoadjuvant therapy for HER2-positive early-stage breast cancer: the future is almost here
Oncology (Williston Park)
.
2012 Jan;26(1):26, 28-9.
Author
Hope S Rugo
1
Affiliation
1
University of California San Francisco, Helen Diller Family Comprehensive Cancer Center, USA.
PMID:
22393793
No abstract available
Publication types
Comment
MeSH terms
Breast Neoplasms / drug therapy*
Female
Humans
Neoadjuvant Therapy*
Receptor, ErbB-2 / antagonists & inhibitors*
Substances
Receptor, ErbB-2